Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 1077


Development and validation of rheumatoid arthritis magnetic resonance imaging inflammation thresholds associated with lack of damage progression.

Baker JF, Østergaard M, Emery P, Baker DG, Conaghan PG.

Clin Exp Rheumatol. 2017 Jan 27. [Epub ahead of print]


Type I interferon-mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy.

Psarras A, Emery P, Vital EM.

Rheumatology (Oxford). 2017 Jan 24. pii: kew431. doi: 10.1093/rheumatology/kew431. [Epub ahead of print]


Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis.

Sellam J, Rivière E, Courties A, Rouzaire PO, Tolusso B, Vital EM, Emery P, Ferracioli G, Soubrier M, Ly B, Chavez HH, Taoufik Y, Dougados M, Mariette X.

Arthritis Res Ther. 2017 Jan 23;19(1):11. doi: 10.1186/s13075-017-1221-4. No abstract available.


Which joints and why do rheumatologists scan in rheumatoid arthritis by ultrasonography? A real life experience.

Aydin SZ, Pay S, Inanc N, Kamali S, Karadag O, Emery P, D'Agostino MA; Targeted Ultrasound Initiative (TUI) Steering Committee..

Clin Exp Rheumatol. 2017 Jan 15. [Epub ahead of print]


Use of optical coherence tomography for the diagnosis of preclinical lesions of circumscribed palmar hypokeratosis.

Abignano G, Kapadia A, Lettieri G, Goodfield M, Emery P, McGonagle D, Del Galdo F, Mikeljevic J.

Clin Exp Dermatol. 2017 Mar;42(2):192-195. doi: 10.1111/ced.13027.


Abatacept reduces disease activity and ultrasound power Doppler in ACPA-negative undifferentiated arthritis: a proof-of-concept clinical and imaging study.

Buch MH, Hensor EM, Rakieh C, Freeston JE, Middleton E, Horton S, Das S, Peterfy C, Tan AL, Wakefield RJ, Emery P.

Rheumatology (Oxford). 2017 Jan;56(1):58-67. doi: 10.1093/rheumatology/kew357.


Physical activity but not sedentary activity is reduced in primary Sjögren's syndrome.

Ng WF, Miller A, Bowman SJ, Price EJ, Kitas GD, Pease C, Emery P, Lanyon P, Hunter J, Gupta M, Giles I, Isenberg D, McLaren J, Regan M, Cooper A, Young-Min SA, McHugh N, Vadivelu S, Moots RJ, Coady D, MacKay K, Dasgupta B, Sutcliffe N, Bombardieri M, Pitzalis C, Griffiths B, Mitchell S, Miyamoto ST, Trenell M; UK Primary Sjögren’s Syndrome Registry..

Rheumatol Int. 2016 Dec 24. doi: 10.1007/s00296-016-3637-6. [Epub ahead of print]


Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren's Syndrome - Capturing the discrepancy.

Bezzina OM, Gallagher P, Mitchell S, Bowman SJ, Griffiths B, Hindmarsh V, Hargreaves B, Price EJ, Pease CT, Emery P, Lanyon P, Bombardieri M, Sutcliffe N, Pitzalis C, Hunter J, Gupta M, McLaren J, Cooper AM, Regan M, Giles IP, Isenberg DA, Vadivelu S, Coady D, Dasgupta B, McHugh NJ, Young-Min SA, Moots RJ, Gendi N, Akil M, MacKay K; UK Primary Sjögren's Syndrome Registry., Ng WF, Robinson LJ.

Arthritis Care Res (Hoboken). 2016 Dec 19. doi: 10.1002/acr.23165. [Epub ahead of print]


2016 update of the EULAR recommendations for the management of early arthritis.

Combe B, Landewe R, Daien CI, Hua C, Aletaha D, Álvaro-Gracia JM, Bakkers M, Brodin N, Burmester GR, Codreanu C, Conway R, Dougados M, Emery P, Ferraccioli G, Fonseca J, Raza K, Silva-Fernández L, Smolen JS, Skingle D, Szekanecz Z, Kvien TK, van der Helm-van Mil A, van Vollenhoven R.

Ann Rheum Dis. 2016 Dec 15. pii: annrheumdis-2016-210602. doi: 10.1136/annrheumdis-2016-210602. [Epub ahead of print]


Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study.

Braun J, Baraliakos X, Deodhar A, Baeten D, Sieper J, Emery P, Readie A, Martin R, Mpofu S, Richards HB; MEASURE 1 study group..

Ann Rheum Dis. 2016 Dec 13. pii: annrheumdis-2016-209730. doi: 10.1136/annrheumdis-2016-209730. [Epub ahead of print]


Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis.

Sellam J, Rivière E, Courties A, Rouzaire PO, Tolusso B, Vital EM, Emery P, Ferraciolli G, Soubrier M, Ly B, Hendel Chavez H, Taoufik Y, Dougados M, Mariette X.

Arthritis Res Ther. 2016 Dec 13;18(1):294. Erratum in: Arthritis Res Ther. 2017 Jan 23;19(1):11.


Is it time to revisit the role of ultrasound in rheumatoid arthritis management?

D'Agostino MA, Boers M, Wakefield RJ, Emery P, Conaghan PG.

Ann Rheum Dis. 2017 Jan;76(1):7-8. doi: 10.1136/annrheumdis-2016-210453. Review.


Identifying arthralgia suspicious for progression to rheumatoid arthritis.

Mankia K, Nam J, Emery P.

Ann Rheum Dis. 2016 Dec 8. pii: annrheumdis-2016-210853. doi: 10.1136/annrheumdis-2016-210853. [Epub ahead of print] No abstract available.


Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.

Dougados M, van der Heijde D, Chen YC, Greenwald M, Drescher E, Liu J, Beattie S, Witt S, de la Torre I, Gaich C, Rooney T, Schlichting D, de Bono S, Emery P.

Ann Rheum Dis. 2017 Jan;76(1):88-95. doi: 10.1136/annrheumdis-2016-210094.


Does high-dose extended course cyclophosphamide and methylprednisolone pulse therapy have a role in the management of systemic sclerosis-related interstitial lung disease?

Abignano G, Bissell LA, Emery P, Del Galdo F, Buch MH.

Rheumatology (Oxford). 2016 Dec;55(12):2273-2275. No abstract available.


Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis-results from the IDEA study.

Bissell LA, Hensor EM, Kozera L, Mackie SL, Burska AN, Nam JL, Keen H, Villeneuve E, Donica H, Buch MH, Conaghan PG, Andrews J, Emery P, Morgan AW.

Rheumatology (Oxford). 2016 Dec;55(12):2181-2190.


T cell subsets: an immunological biomarker to predict progression to clinical arthritis in ACPA-positive individuals.

Hunt L, Hensor EM, Nam J, Burska AN, Parmar R, Emery P, Ponchel F.

Ann Rheum Dis. 2016 Oct;75(10):1884-9. doi: 10.1136/annrheumdis-2015-207991.


Novel algorithms for the pragmatic use of ultrasound in the management of patients with rheumatoid arthritis: from diagnosis to remission.

D'Agostino MA, Terslev L, Wakefield R, Østergaard M, Balint P, Naredo E, Iagnocco A, Backhaus M, Grassi W, Emery P.

Ann Rheum Dis. 2016 Nov;75(11):1902-1908. doi: 10.1136/annrheumdis-2016-209646. Review.


Absence of Scleroderma pattern at nail fold capillaroscopy valuable in the exclusion of Scleroderma in unselected patients with Raynaud's Phenomenon.

Bissell LA, Abignano G, Emery P, Del Galdo F, Buch MH.

BMC Musculoskelet Disord. 2016 Aug 15;17(1):342. doi: 10.1186/s12891-016-1206-5.

Items per page

Supplemental Content

Support Center